Literature DB >> 32992337

Postoperative Pain Management in Patients With Ulcerative Colitis.

Norika Katagiri1, Ryutaro Sakai1, Takashi Izutsu2, Hiromasa Kawana3, Shigekazu Sugino4, Kanta Kido1.   

Abstract

Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders of the gastrointestinal tract including ulcerative colitis (UC) and Crohn's disease. Pain management can be challenging in patients with IBD because there are limitations on the use of analgesics. Use of nonsteroidal anti-inflammatory drugs is not recommended in patients with IBD because there is risk of relapse of IBD and an overall increase in disease activity. Opioids, although frequently used for treating severe acute pain, can have additional risks and complications in patients with IBD such as ileus, toxic megacolon, and narcotic bowel syndrome. Furthermore, little information is available in the literature on pain management in these patients undergoing noncolorectal surgery. This report describes 2 patients with UC in whom postoperative pain following oral and maxillofacial surgery was managed by intravenous patient-controlled analgesia with pentazocine. Apart from the development of acute dystonia in 1 case that was likely due to the use of droperidol for prevention of postoperative nausea and vomiting, postoperative pain was well controlled by pentazocine in both patients without any complications or UC exacerbations.
© 2020 by the American Dental Society of Anesthesiology.

Entities:  

Keywords:  Inflammatory bowel disease; Pentazocine; Postoperative pain management; Ulcerative colitis

Mesh:

Year:  2020        PMID: 32992337      PMCID: PMC7530804          DOI: 10.2344/anpr-67-01-06

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  27 in total

1.  Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study.

Authors:  J B Felder; B I Korelitz; R Rajapakse; S Schwarz; A P Horatagis; G Gleim
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 2.  Management of acute postoperative pain after oral surgery.

Authors:  Mark C Fletcher; Joseph F Spera
Journal:  Dent Clin North Am       Date:  2012-01

Review 3.  Treatment of opioid-induced gut dysfunction.

Authors:  Peter Holzer
Journal:  Expert Opin Investig Drugs       Date:  2007-02       Impact factor: 6.206

4.  Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Authors:  Millie D Long; Edward L Barnes; Hans H Herfarth; Douglas A Drossman
Journal:  Inflamm Bowel Dis       Date:  2011-07-07       Impact factor: 5.325

5.  Managing pain in inflammatory bowel disease.

Authors:  Michael J Docherty; R Carter W Jones; Mark S Wallace
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-09

Review 6.  Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review.

Authors:  M Hyllested; S Jones; J L Pedersen; H Kehlet
Journal:  Br J Anaesth       Date:  2002-02       Impact factor: 9.166

7.  The opioid system in the gastrointestinal tract.

Authors:  C Sternini; S Patierno; I-S Selmer; A Kirchgessner
Journal:  Neurogastroenterol Motil       Date:  2004-10       Impact factor: 3.598

8.  Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.

Authors:  Ken Takeuchi; Simon Smale; Purushothaman Premchand; Laurence Maiden; Roy Sherwood; Bjarni Thjodleifsson; Einar Bjornsson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2006-02       Impact factor: 11.382

Review 9.  IBD and genetics: new developments.

Authors:  L E Oostenbrug; H M van Dullemen; G J te Meerman; P L M Jansen
Journal:  Scand J Gastroenterol Suppl       Date:  2003

10.  Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome.

Authors:  Lawrence A Szarka; Michael Camilleri; Duane Burton; Jean C Fox; Sanna McKinzie; Timothy Stanislav; Julie Simonson; Nancy Sullivan; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2007-09-27       Impact factor: 11.382

View more
  1 in total

1.  Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.

Authors:  Nestor Nivardo Jiménez-Vargas; Yang Yu; Dane D Jensen; Diana Daeun Bok; Matthew Wisdom; Rocco Latorre; Cintya Lopez; Josue O Jaramillo-Polanco; Claudius Degro; Mabel Guzman-Rodriguez; Quentin Tsang; Zachary Snow; Brian L Schmidt; David E Reed; Alan Edward Lomax; Kara Gross Margolis; Christoph Stein; Nigel W Bunnett; Stephen J Vanner
Journal:  Gut       Date:  2021-03-30       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.